Cancer Drugs Prices

To most of us it’s hardly surprising!! A new analysis found that the claim by drug companies justifying the high price of drugs by the expenses of research and development cannot be proven. In an article published in JAMA Internal Medicine, the researchers found that the cost of developing a new drug is around $650 million. The drug companies put that cost at $ 2.7 billion or several times the actual cost established by the researchers. On top of the $650 million the researchers add another $100 million to cover the cost of what the companies would have gained by Continue reading “Cancer Drugs Prices”